Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ELECTHANE

Financiado

Cerrado

Microbiological conversion of renewable electricity and CO2 to a natural gas qua...

Microbiological conversion of renewable electricity and CO2 to a natural gas quality bio fuel OWS wants to commercialize a biological process that converts CO2 and H2 (after electrolysis of renewable electricity) to CH4 (main component in natural gas). Lab and pilot tests have been and are being conducted and show promisin... ver más

31/05/2016

OWS NV

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

NORMEC OWS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2016-05-31

SIE-01-2014-1: Stimulating the innovation potentia...

I+D

Cerrada hace 10 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

OWS NV

50.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

NIAGARA Next advanced bIofuels from AlGae biomAss and oRganic biogen... 4M€ Cerrado

PTQ-08-01-06447 Estudio de viabilidad técnica para la revalorización de biog... 57K€ Cerrado

PRE2018-083634 CONVERSION DE BIOGAS EN BIO-HIDROGENO EN UNA SOLA ETAPA: REF... 93K€ Cerrado

eForFuel Fuels from electricity de novo metabolic conversion of elec... 4M€ Cerrado

IPT-310000-2010-035 Bioproducción de hidrógeno en reactores anaeróbicos a partir... 234K€ Cerrado

RTI2018-102161-B-I00 CONVERSION DIRECTA DE CO2 EN PORTADORES DE ENERGIA QUIMICA U... 266K€ Cerrado

Duración del proyecto: 12 meses Fecha Inicio: 2015-05-06
Fecha Fin: 2016-05-31

Líder del proyecto

NORMEC OWS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto OWS wants to commercialize a biological process that converts CO2 and H2 (after electrolysis of renewable electricity) to CH4 (main component in natural gas). Lab and pilot tests have been and are being conducted and show promising results. A next step in the development is creating a sound business model for further commercialization, and the construction of a first plant at full-scale for further optimization and demonstration purposes to potential clients. As renewable energy sources are gaining more ground in the electricity mix in Europe, imbalance problems on the electricity grid will increase in frequency. The proposed concept offers a solution to this imbalance problem by converting excess electricity via hydrolysis to H2 and using (waste) CO2 to CH4 that can be injected into the gas grid. The advantage of the proposed system is the small scale (< 10 MWe), so the conversion can be done near the production sites. When there is an excess of renewable electricity, fees are paid to the operators of renewable electricity for not producing, thus avoiding grid imbalance. Although this approach is understandable from a balancing perspective, it is contradictory to a sustainable approach and in conflict with the existing renewable energy targets. Therefore, producers of renewable electricity are a first important target group for our technology. CO2-intensive industries are a second important target group. By recycling their waste CO2, they become more sustainable, and it can generate extra revenues from buffering activities. During the feasibility study, OWS wants to elaborate a sound business plan for further development of the technology. It should result in a clear vision on technical, economic and legal issues. The final goal is to build a first full-scale demonstration plant in phase 2, which can serve as a test facility for further optimization (technical/biological), but also as a demonstration plant for potential customers.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores